Parlar_2022_Arch.Pharm.(Weinheim)__e2200519

Reference

Title : N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity - Parlar_2022_Arch.Pharm.(Weinheim)__e2200519
Author(s) : Parlar S , Sayar G , Tarikogullari AH , Karadagli SS , Alan E , Sevin G , Erciyas E , Holzgrabe U , Alptuzun V
Ref : Arch Pharm (Weinheim) , :e2200519 , 2022
Abstract : Parlar_2022_Arch.Pharm.(Weinheim)__e2200519
ESTHER : Parlar_2022_Arch.Pharm.(Weinheim)__e2200519
PubMedSearch : Parlar_2022_Arch.Pharm.(Weinheim)__e2200519
PubMedID: 36461719

Related information

Citations formats

Parlar S, Sayar G, Tarikogullari AH, Karadagli SS, Alan E, Sevin G, Erciyas E, Holzgrabe U, Alptuzun V (2022)
N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity
Arch Pharm (Weinheim) :e2200519

Parlar S, Sayar G, Tarikogullari AH, Karadagli SS, Alan E, Sevin G, Erciyas E, Holzgrabe U, Alptuzun V (2022)
Arch Pharm (Weinheim) :e2200519